# DECIFER: Depression and Citalopram In First Episode Recovery

> **NCT01041274** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 95 (actual)

## Conditions studied

- Schizophrenia
- Schizophreniform Disorder

## Interventions

- **DRUG:** Citalopram
- **DRUG:** Placebo
- **BEHAVIORAL:** Psychoeducation
- **BEHAVIORAL:** Cognitive Behavioral Therapy (CBT)
- **RADIATION:** Functional Magnetic Resonance Imaging (fMRI)

## Key facts

- **NCT ID:** NCT01041274
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-12
- **Final completion:** 2018-03-26
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041274, "DECIFER: Depression and Citalopram In First Episode Recovery". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01041274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*